The genetic inheritance of specific risk alleles is widely accepted as a major contributing factor to many, if not all, mental illnesses. Moreover, recent studies found that the precise epigenetic regulation of gene expression is critical for normal learning and memory processes and is often disrupted in the diseased brain. However, despite recent concerted efforts of numerous neuroscientists and physicians, the links between precise molecular and synaptic defects resulting from (epi)genetic variation and specific brain circuit abnormalities that result in particular behavioral disorders remain rather poorly understood. Given the ongoing avalanche of new genetic/genomic data associated with neuropsychiatric disorders, there is a rapidly expanding need to train the next generation of neuroscientists to be facile in both modern molecular genetic approaches in different model systems, as well as in cutting edge molecular bioinformatics techniques that are required to link individual genes to normal brain functions and disease processes. The over-arching goal of this multi-disciplinary postdoctoral Training Program in Functional Neurogenomics is to support a training pipeline that fosters the development of new investigators with these skills. This competing renewal application will demonstrate an advancement and evolution in both the available training mentors and in cutting edge inter-disciplinary technical capabilities that builds on the substantial prior successes of this long-running program. Our efforts are supported by significant ongoing investments by Vanderbilt in new neuroscience leadership, faculty, educational programs, technological expertise and core facilities. Taken together, this provides a robust and rigorous environment for trainees to gain expertise in opportunities afforded by genetic model systems, the translation of human genetic findings into construct-valid animal models, in vivo manipulations of molecules, cells and circuits using advanced approaches, and in capturing the epigenetic, physiological, and behavioral consequences of such manipulations. The Program Director is Roger J. Colbran, Ph.D., Professor and Interim Chair of the Department of Molecular Physiology & Biophysics. Dr. Colbran has a long-standing, well-funded program investigating molecular mechanisms involved in synaptic plasticity using multi-disciplinary approaches from biochemical structure-function to mouse genetics and behavior. The Co-Director, J. David Sweatt, Ph.D., was recently recruited to Vanderbilt as the Chair of the Department of Pharmacology and has previously served on both the NIMH Advisory Council and the NIMH intramural program Board of Scientific Councilors. Dr. Sweatt has made numerous highly-cited contributions to understanding mechanisms underlying learning and memory in previous positions at Baylor College of Medicine and UAB, with a particular recent focus on the role of epigenetics in cognition and neural plasticity. The program leadership has a long-standing commitment to mentoring the next generation of neuroscientists, with a strong track record of facilitating the establishment of enduring and productive research careers for their trainees.

Public Health Relevance

Neurobehavioral disorders, such as autism, obsessive-compulsive disorder, schizophrenia, bipolar disorder, eating disorders and depression, reduce the quality of life and productivity for tens of millions of Americans each year. We now appreciate that inherited or de novo genetic changes and specific environmental exposures are associated with many, if not all, of these disorders, but the impact of these factors on molecules that are involved in normal brain function and their roles in specific behavioral abnormalities is very poorly defined. The goal of the Vanderbilt Postdoctoral Training Program in Functional Neurogenomics is to train our fellows in state-of-the-art concepts and techniques that are needed to provide both a fundamental understanding of these processes and a platform for the development of novel medications to treat these devastating illnesses, and closely mentor them toward future careers as independent scientists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Institutional National Research Service Award (T32)
Project #
2T32MH065215-16A1
Application #
9702544
Study Section
Special Emphasis Panel (ZMH1)
Program Officer
Van'T Veer, Ashlee V
Project Start
2002-07-15
Project End
2024-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
16
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
965717143
City
Nashville
State
TN
Country
United States
Zip Code
37203
Stewart, Adele; Davis, Gwynne L; Gresch, Paul J et al. (2018) Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology :
Morgan, Amanda J; Kingsley, Philip J; Mitchener, Michelle M et al. (2018) Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. ACS Chem Neurosci 9:1552-1559
Fisher, Nicole M; Gogliotti, Rocco G; Vermudez, Sheryl Anne D et al. (2018) Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome. ACS Chem Neurosci 9:2210-2217
Stansley, Branden J; Fisher, Nicole M; Gogliotti, Rocco G et al. (2018) Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5. Cereb Cortex 28:4291-4304
Yohn, Samantha E; Conn, P Jeffrey (2018) Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia. Neuropharmacology 136:438-448
Vranjkovic, Oliver; Winkler, Garrett; Winder, Danny G (2018) Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances. Neuropsychopharmacology 43:1915-1923
Stephenson, Jason R; Wang, Xiaohan; Perfitt, Tyler L et al. (2017) A Novel Human CAMK2A Mutation Disrupts Dendritic Morphology and Synaptic Transmission, and Causes ASD-Related Behaviors. J Neurosci 37:2216-2233
Dohn, Michael R; Kooker, Christopher G; Bastarache, Lisa et al. (2017) The Gain-of-Function Integrin ?3 Pro33 Variant Alters the Serotonin System in the Mouse Brain. J Neurosci 37:11271-11284
Robinson, Sarah B; Hardaway, J Andrew; Hardie, Shannon L et al. (2017) Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization. Mol Cell Neurosci 78:41-51
Rogers, Tiffany D; Anacker, Allison M J; Kerr, Travis M et al. (2017) Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome. Mol Autism 8:30

Showing the most recent 10 out of 162 publications